Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Hartzen

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Ugeskrift for Laeger|August 6, 1990
[Fluconazole. A new antimycotic for systemic use]S H Hartzen, N Frimodt-Møller, B Korner
Cancer|May 1, 1986
A, B, H antigen expression in transitional cell carcinomas of the urinary bladderB R Juhl, S H Hartzen, B Hainau
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 1, 1994
The antibacterial activity of a siderophore. 3. The activity of deferoxamine in vitro and its influence on the effect of antibiotics against Escherichia coli, Proteus mirabilis and coagulase-negative staphylococciS H Hartzen, N Frimodt-Møller, V F Thomsen
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 1, 1988
In vitro antibacterial activities of eleven antibiotics against S. faecalisS H Hartzen, N Frimodt-Möller, J J Andreasen
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 1, 1991
The antibacterial activity of a siderophore. 2. The influence of deferoxamine alone and combined with ascorbic acid on the activity of antibiotics against Staphylococcus aureusS H Hartzen, N Frimodt-Møller, V F Thomsen
CNS & Neurological Disorders Drug Targets|September 30, 2010
Meningococcal disease and future drug targetsL K Gammelgaard, H Colding, S H Hartzen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 1, 1988
In vitro susceptibility of diarrhoea producing gram negative enteric bacteria to sulfasalazine, 5-aminosalicylic acid, sulfapyridine and four quinolones. Brief reportJ J Andreasen, L P Andersen, S H Hartzen
Ugeskrift for Laeger|August 30, 2000
[Hygiene in general practice]H Korsholm, A Ibsen, S H Hartzen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 1, 1989
The antibacterial activity of a siderophore. 1. In vitro activity of deferoxamine alone and in combination with ascorbic acid on Staphylococcus aureusS H Hartzen, N Frimodt-Møller, V Frølund Thomsen
The Journal of Antimicrobial Chemotherapy|July 1, 1986
Relationship between penicillinase production and the in-vitro activity of methicillin, oxacillin, cloxacillin, dicloxacillin, flucloxacillin, and cephalothin against strains of Staphylococcus aureus of different phage patterns and penicillinase activityN Frimodt-Møller, V T Rosdahl, G Sørensen, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Ugeskrift for Laeger|August 6, 1990
[Fluconazole. A new antimycotic for systemic use]S H Hartzen, N Frimodt-Møller, B Korner
Cancer|May 1, 1986
A, B, H antigen expression in transitional cell carcinomas of the urinary bladderB R Juhl, S H Hartzen, B Hainau
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 1, 1994
The antibacterial activity of a siderophore. 3. The activity of deferoxamine in vitro and its influence on the effect of antibiotics against Escherichia coli, Proteus mirabilis and coagulase-negative staphylococciS H Hartzen, N Frimodt-Møller, V F Thomsen
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 1, 1988
In vitro antibacterial activities of eleven antibiotics against S. faecalisS H Hartzen, N Frimodt-Möller, J J Andreasen
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 1, 1991
The antibacterial activity of a siderophore. 2. The influence of deferoxamine alone and combined with ascorbic acid on the activity of antibiotics against Staphylococcus aureusS H Hartzen, N Frimodt-Møller, V F Thomsen
CNS & Neurological Disorders Drug Targets|September 30, 2010
Meningococcal disease and future drug targetsL K Gammelgaard, H Colding, S H Hartzen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 1, 1988
In vitro susceptibility of diarrhoea producing gram negative enteric bacteria to sulfasalazine, 5-aminosalicylic acid, sulfapyridine and four quinolones. Brief reportJ J Andreasen, L P Andersen, S H Hartzen
Ugeskrift for Laeger|August 30, 2000
[Hygiene in general practice]H Korsholm, A Ibsen, S H Hartzen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 1, 1989
The antibacterial activity of a siderophore. 1. In vitro activity of deferoxamine alone and in combination with ascorbic acid on Staphylococcus aureusS H Hartzen, N Frimodt-Møller, V Frølund Thomsen
The Journal of Antimicrobial Chemotherapy|July 1, 1986
Relationship between penicillinase production and the in-vitro activity of methicillin, oxacillin, cloxacillin, dicloxacillin, flucloxacillin, and cephalothin against strains of Staphylococcus aureus of different phage patterns and penicillinase activityN Frimodt-Møller, V T Rosdahl, G Sørensen, et al.
Pageof 3